220 related articles for article (PubMed ID: 18378677)
1. Noonan syndrome-associated SHP-2/Ptpn11 mutants enhance SIRPalpha and PZR tyrosyl phosphorylation and promote adhesion-mediated ERK activation.
Eminaga S; Bennett AM
J Biol Chem; 2008 May; 283(22):15328-38. PubMed ID: 18378677
[TBL] [Abstract][Full Text] [Related]
2. PZR coordinates Shp2 Noonan and LEOPARD syndrome signaling in zebrafish and mice.
Paardekooper Overman J; Yi JS; Bonetti M; Soulsby M; Preisinger C; Stokes MP; Hui L; Silva JC; Overvoorde J; Giansanti P; Heck AJ; Kontaridis MI; den Hertog J; Bennett AM
Mol Cell Biol; 2014 Aug; 34(15):2874-89. PubMed ID: 24865967
[TBL] [Abstract][Full Text] [Related]
3. Tyrosyl phosphorylation of PZR promotes hypertrophic cardiomyopathy in PTPN11-associated Noonan syndrome with multiple lentigines.
Yi JS; Perla S; Enyenihi L; Bennett AM
JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32584792
[TBL] [Abstract][Full Text] [Related]
4. Low-dose dasatinib rescues cardiac function in Noonan syndrome.
Yi JS; Huang Y; Kwaczala AT; Kuo IY; Ehrlich BE; Campbell SG; Giordano FJ; Bennett AM
JCI Insight; 2016 Dec; 1(20):e90220. PubMed ID: 27942593
[TBL] [Abstract][Full Text] [Related]
5. Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature.
De Rocca Serra-Nédélec A; Edouard T; Tréguer K; Tajan M; Araki T; Dance M; Mus M; Montagner A; Tauber M; Salles JP; Valet P; Neel BG; Raynal P; Yart A
Proc Natl Acad Sci U S A; 2012 Mar; 109(11):4257-62. PubMed ID: 22371576
[TBL] [Abstract][Full Text] [Related]
6. Dissecting the interaction of SHP-2 with PZR, an immunoglobulin family protein containing immunoreceptor tyrosine-based inhibitory motifs.
Zhao R; Zhao ZJ
J Biol Chem; 2000 Feb; 275(8):5453-9. PubMed ID: 10681522
[TBL] [Abstract][Full Text] [Related]
7. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
Fragale A; Tartaglia M; Wu J; Gelb BD
Hum Mutat; 2004 Mar; 23(3):267-77. PubMed ID: 14974085
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone regulation of SIRP and SHP-2 tyrosyl phosphorylation and association.
Stofega MR; Wang H; Ullrich A; Carter-Su C
J Biol Chem; 1998 Mar; 273(12):7112-7. PubMed ID: 9507023
[TBL] [Abstract][Full Text] [Related]
9. Gain-of-function/Noonan syndrome SHP-2/Ptpn11 mutants enhance calcium oscillations and impair NFAT signaling.
Uhlén P; Burch PM; Zito CI; Estrada M; Ehrlich BE; Bennett AM
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2160-5. PubMed ID: 16461457
[TBL] [Abstract][Full Text] [Related]
10. Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia.
Niihori T; Aoki Y; Ohashi H; Kurosawa K; Kondoh T; Ishikiriyama S; Kawame H; Kamasaki H; Yamanaka T; Takada F; Nishio K; Sakurai M; Tamai H; Nagashima T; Suzuki Y; Kure S; Fujii K; Imaizumi M; Matsubara Y
J Hum Genet; 2005; 50(4):192-202. PubMed ID: 15834506
[TBL] [Abstract][Full Text] [Related]
11. Noonan syndrome/leukemia-associated gain-of-function mutations in SHP-2 phosphatase (PTPN11) enhance cell migration and angiogenesis.
Wang S; Yu WM; Zhang W; McCrae KR; Neel BG; Qu CK
J Biol Chem; 2009 Jan; 284(2):913-20. PubMed ID: 19008228
[TBL] [Abstract][Full Text] [Related]
12. Regulation of early events in integrin signaling by protein tyrosine phosphatase SHP-2.
Oh ES; Gu H; Saxton TM; Timms JF; Hausdorff S; Frevert EU; Kahn BB; Pawson T; Neel BG; Thomas SM
Mol Cell Biol; 1999 Apr; 19(4):3205-15. PubMed ID: 10082587
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine phosphatase SHP-2 regulates IL-1 signaling in fibroblasts through focal adhesions.
Herrera Abreu MT; Wang Q; Vachon E; Suzuki T; Chow CW; Wang Y; Hong O; Villar J; McCulloch CA; Downey GP
J Cell Physiol; 2006 Apr; 207(1):132-43. PubMed ID: 16250012
[TBL] [Abstract][Full Text] [Related]
14. Novel mesenchymal and haematopoietic cell isoforms of the SHP-2 docking receptor, PZR: identification, molecular cloning and effects on cell migration.
Zannettino AC; Roubelakis M; Welldon KJ; Jackson DE; Simmons PJ; Bendall LJ; Henniker A; Harrison KL; Niutta S; Bradstock KF; Watt SM
Biochem J; 2003 Mar; 370(Pt 2):537-49. PubMed ID: 12410637
[TBL] [Abstract][Full Text] [Related]
15. Signal regulatory proteins negatively regulate immunoreceptor-dependent cell activation.
Liénard H; Bruhns P; Malbec O; Fridman WH; Daëron M
J Biol Chem; 1999 Nov; 274(45):32493-9. PubMed ID: 10542295
[TBL] [Abstract][Full Text] [Related]
16. P
Roubelakis MG; Tsaknakis G; Lyu FJ; Trohatou O; Zannettino ACW; Watt SM
Cells; 2020 Apr; 9(5):. PubMed ID: 32365526
[TBL] [Abstract][Full Text] [Related]
17. A role for SHPS-1/SIRPalpha in Concanavalin A-dependent production of MMP-9.
Ruhul Amin AR; Uddin Biswas MH; Senga T; Feng GS; Kannagi R; Agarwal ML; Hamaguchi M
Genes Cells; 2007 Sep; 12(9):1023-33. PubMed ID: 17825046
[TBL] [Abstract][Full Text] [Related]
18. Transgenic Drosophila models of Noonan syndrome causing PTPN11 gain-of-function mutations.
Oishi K; Gaengel K; Krishnamoorthy S; Kamiya K; Kim IK; Ying H; Weber U; Perkins LA; Tartaglia M; Mlodzik M; Pick L; Gelb BD
Hum Mol Genet; 2006 Feb; 15(4):543-53. PubMed ID: 16399795
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation and localization of protein-zero related (PZR) in cultured endothelial cells.
Kusano K; Thomas TN; Fujiwara K
Endothelium; 2008; 15(3):127-36. PubMed ID: 18568953
[TBL] [Abstract][Full Text] [Related]
20. The ability of protein tyrosine phosphatase SHP-1 to suppress NFkappaB can be inhibited by dominant negative mutant of SIRPalpha.
Neznanov N; Neznanova L; Kondratov RV; O'Rourke DM; Ullrich A; Gudkov AV
DNA Cell Biol; 2004 Mar; 23(3):175-82. PubMed ID: 15068587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
